Hazlett, Burt & Watson’s Sanofi SNY Stock Holding History

Hazlett, Burt & Watson’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-965	Closed	-$54K	–	857
2025 Q1	$54K	Hold	965	–	–	0.02%	345
2024 Q4	$47K	Hold	965	–	–	0.02%	366
2024 Q3	$56K	Hold	965	–	–	0.03%	339
2024 Q2	$47K	Hold	965	–	–	0.02%	345
2024 Q1	$47K	Hold	965	–	–	0.03%	334
2023 Q4	$48K	Sell	965 -30	-3%	-$1.47K	0.03%	314
2023 Q3	$54K	Buy	995 +30	+3%	+$1.6K	0.04%	293
2023 Q2	$52K	Hold	965	–	–	0.04%	294
2023 Q1	$53K	Hold	965	–	–	0.04%	270
2022 Q4	$47K	Hold	965	–	–	0.04%	280
2022 Q3	$37K	Hold	965	–	–	0.04%	300
2022 Q2	$48K	Hold	965	–	–	0.04%	275
2022 Q1	$50K	Buy	+965	New	+$49.8K	0.04%	291

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hazlett, Burt & Watson's SNY Position: Q2 2025 in Review

Hazlett, Burt & Watson sold out of Sanofi (SNY) in Q2 2025, closing a stake of 965 shares — an estimated $54K sold.

Hazlett, Burt & Watson first reported a position in SNY in Q1 2022 and held it in 13 quarters. The position peaked at $56K in Q3 2024. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

Hazlett, Burt & Watson reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
Hazlett, Burt & Watson sold 965 Sanofi shares in Q2 2025, an estimated $54K.
Hazlett, Burt & Watson first reported a position in Sanofi in Q1 2022 and held it in 13 quarters.
Hazlett, Burt & Watson's Sanofi position peaked at $56K in Q3 2024.
731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2025, filed 25 Jul 2025.